Enliven Therapeutics Inc. Financial Flexibility Index
Enliven Therapeutics Inc. financial flexibility index. Enliven Therapeutics Inc. (ELVN) has a Financial Flexibility Index of -1.22x as of June 2026. Free cash flow of $-18.43 Million (operating CF $-18.53 Million minus capex $99.00K) represents -1% of total liabilities ($15.07 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Enliven Therapeutics Inc. (2017–2025)
Financial flexibility index of Enliven Therapeutics Inc. from 2017 to 2025. Historical Financial Flexibility Index trend for Enliven Therapeutics Inc. across 9 annual periods. Explore cash flow to debt ratio of Enliven Therapeutics Inc. to assess how comfortably operating cash covers total debt obligations.
Enliven Therapeutics Inc. Financial Flexibility Index by Year (2017–2025)
Enliven Therapeutics Inc. financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for Enliven Therapeutics Inc.. For the full cash flow conversion analysis, see ELVN cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.21x | $-70.14 Million | $-70.30 Million | $16.68 Million | ▲ +8.5% |
| 2024 | -4.60x | $-73.15 Million | $-73.19 Million | $15.91 Million | ▼ -95.2% |
| 2023 | -2.35x | $-61.12 Million | $-61.27 Million | $25.96 Million | ▼ -1098.1% |
| 2022 | -0.20x | $-31.46 Million | $-32.08 Million | $160.12 Million | ▲ +93.3% |
| 2021 | -2.93x | $-18.94 Million | $-19.13 Million | $6.47 Million | ▼ -132.6% |
| 2020 | -1.26x | $-8.07 Million | $-8.53 Million | $6.41 Million | ▲ +74.6% |
| 2019 | -4.96x | $-21.74 Million | $-21.88 Million | $4.38 Million | ▼ -3.5% |
| 2018 | -4.79x | $-8.78 Million | $-8.78 Million | $1.83 Million | ▲ +19.0% |
| 2017 | -5.91x | $-8.79 Million | $-8.79 Million | $1.49 Million | — |